ArticlePloS one2025
Broad-spectrum eye disease classification using a deep learning-based tailored software lens.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The early and accurate classification of eye diseases is essential for preventing irreversible visual impairment. This task can be performed by deep learning approaches that automatically classify retinal fundus images according to potential illnesses. Despite notable advances in this field, the robust and methodologically rigorous classification of a broad range of eye diseases remains unsolved. This study addresses this issue by proposing a novel deep learning architecture that leverages specific features of retinal fundus images (e.g., image noise and importance of fine structures) using a tailored software lens to robustly diagnose a broad spectrum of illnesses at a high performance level. To validate this approach, the currently broadest peer-reviewed dataset of 16,242 images, comprising nine diseases and healthy samples, is chosen. Our novel architecture achieves a 5-fold cross-validated average balanced accuracy of 82.52 %, outperforming the baseline model (79.40 %) and setting a new benchmark. Our results demonstrate for the first time that high performance can be achieved for diagnosing a broad range of eye diseases based on retinal fundus images by leveraging their specific features. This approach has implications for clinical deployment, particularly in routine care settings, by enabling faster and more reliable screenings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.